Novo Nordisk invests in facility expansion at production site in Denmark
Production site in Måløv, Denmark manufactures products for oral diabetes treatment Rybelsus
Read More
Tag: Rybelsus
UK launch for Novo’s new diabetes pill
Rybelsus is the world’s first and only oral GLP-1 receptor agonist
Read More
